Nuclear Medicine in Belgium

14 – 15 Oct 2026 | Suarlée, Belgium

HomeAgendaParticipantsMarketplace

Exo Biologics

Company

Liège, Belgium

About

Exo Biologics is a clinical-stage biotechnology company developing extracellular vesicle (EV)-based therapeutics for inflammatory, neurological, and regenerative diseases. Its lead candidate, EXOB-001, is currently in Phase I/II clinical development.

As part of Shuttle to Brain, an Interreg project, Exo Biologics uses radioligands to investigate the biodistribution of its EVs. The project also aims to explore the potential of EVs as delivery vehicles for therapeutic payloads to the brain.

Areas of activity

Application Domain

BiopharmaAdvanced Therapies

Technology

Biologics

Therapeutic Area

ImmunologyNeurologyPediatricsPneumologyRare Diseases

Representatives

CBO

Exo Biologics